FDA MedWatch Safety AlertsOriginal article
Baxter Issues Voluntary Nationwide Recall of Cefazolin in Dextrose Injection, USP, 2G / 100ml(20mg /ml) Single-Dose Infusion Bag in 100ml Due to Particulate Matter Found in Solution
RegulatoryCefazolin in Dextrose Injection, USPNegative
AI Analysis
Summary
Baxter International issued a voluntary nationwide recall of Cefazolin in Dextrose Injection (2G/100ml) Lot LD175708 (expiration 14-Feb 2027) due to particulate matter identified as cardboard contamination in the solution.
Outcome Details
Voluntary nationwide recall of specific lot due to particulate matter (cardboard) found in solution
Importance:3/10
Sentiment:
-0.80
product recallsafetyquality controlFDA MedWatchvoluntary recall
Related Companies
Read the original article
Published by FDA MedWatch Safety Alerts on July 24, 2026 4:00 AM